SPC2996
Facts from the Community
From the BioVenturist base
Target/Biomolecule of Interest:
Indication or disease:
| Disease | Phase of development | Notes |
|---|---|---|
|
||
Technology involved:
Developed by:
Stage of development:
We can tell you that SPC2996 is a…
If you know more about SPC2996, you can add more facts here »
Similar topics in Freebase
-
ALN-VSP01
-
ALN-HTT
-
PLK1 SNALP
PLK1 SNALP is being developed as an anti-tumor therapeutic. It is using siRNA encapsulated in the SNALP (stable nucleic acid-lipid particles) delivery technology. -
CEQ501
-
ALN-PCS
-
SPC-RNAi-ApoB
